Insulin Resistance Global Clinical Trials Review, H2, 2015

1
Insulin Resistance Global Clinical Trials Review,
H2, 2015
(Type, Mode of action, Crop Type and Geography) -
Size, Share, Global Trends, Company Profiles,
Demand, Insights, Analysis, Research, Report,
Opportunities, Segmentation and Forecast, 2013 -
2020
TELEPHONE [phone]E-MAIL
sales_at_researchbeam.com
Published on Oct 2014
2


Report Overview

• Insulin Resistance Global Clinical Trials Review,
  H2, 2015 provides an overview of Insulin
  Resistance clinical trials scenario. This report
  provides top line data relating to the clinical
  trials on Insulin Resistance. Report includes an
  overview of trial numbers and their average
  enrollment in top countries conducted across the
  globe. The report offers coverage of disease
  clinical trials by region, country (G7 E7) ,
  phase, trial status, end points status and
  sponsor type. Report also provides prominent
  drugs for in-progress trials (based on number of
  ongoing trials) . Clinical Trial Reports are
  generated using proprietary database Pharma
  eTrack Clinical trials database. Clinical trials
  are collated from 80 different clinical trial
  registries, conferences, journals, news etc
  across the globe. Clinical trials database
  undergoes periodic update by dynamic process.
• Scope
• The report provides a snapshot of the global
  clinical trials landscape
• Report provides top level data related to the
  clinical trials by Region, Country (G7 E7) ,
  Trial Status, Trial Phase, Sponsor Type and End
  point status
• The report reviews top companies involved and
  enlists all trials (Trial title, Phase, and
  Status) pertaining to the company
• The report provides all the unaccomplished trials
  (Terminated, Suspended and Withdrawn) with reason
  for unaccomplishment
• The Report provides enrollment trends for the
  past five years
• Report provides latest news for the past three
  months
• Read More At http//www.researchbeam.com/insuli
  n-resistance-global-clinical-trials-review-h2-2015
  -market

3


Table of Content
Table of Contents 2 List of Tables 3 List of
Figures 4 Report Guidance 5 Clinical Trials by
Region 6 Clinical Trials and Average Enrollment
by Country 7 Top Five Countries Contributing to
Clinical Trials in Asia-Pacific 9 Top Five
Countries Contributing to Clinical Trials in
Europe 10 Top Countries Contributing to Clinical
Trials in North America 11 Top Five Countries
Contributing to Clinical Trials in Middle East
and Africa 12 Top Countries Contributing to
Clinical Trials in Central and South America
13 Clinical Trials by G7 Countries Proportion of
Insulin Resistance to Metabolic Disorders
Clinical Trials 14 Clinical Trials by Phase in G7
Countries 15 Clinical Trials in G7 Countries by
Trial Status 16 Clinical Trials by E7 Countries
Proportion of Insulin Resistance to Metabolic
Disorders Clinical Trials 17 Clinical Trials by
Phase in E7 Countries 18 Clinical Trials in E7
Countries by Trial Status 19 Clinical Trials by
Phase 20 In Progress Trials by Phase 21
4


Table of Content
Clinical Trials by Trial Status 22 Clinical
Trials by End Point Status 23 Subjects Recruited
Over a Period of Time 24 Clinical Trials by
Sponsor Type 25 Prominent Sponsors 26 Top
Companies Participating in Insulin Resistance
Therapeutics Clinical Trials 27 Prominent Drugs
28 Clinical Trial Profile Snapshots 29 Appendix
374 Abbreviations 374 Definitions 374 Research
Methodology 375 Secondary Research 375 About
GlobalData 376 Contact Us 376 Disclaimer
376 Source 377 Enquire At http//www.researchb
eam.com/insulin-resistance-global-clinical-trials-
review-h2-2015-market/enquire-about-report
5



FOR MORE DETAILS
Visit us at
http//www.researchbeam.com/insulin-resistance-glo
bal-clinical-trials-review-h2-2015-market
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE [phone] DIRECT 1 (503)
894-6022E-MAIL sales_at_researchbeam.com